Suppr超能文献

加州极低出生体重婴儿无重大并发症存活率。

Survival Without Major Morbidity Among Very Low Birth Weight Infants in California.

机构信息

Perinatal Epidemiology and Health Outcomes Research Unit, Division of Neonatal and Developmental Medicine, Department of Pediatrics, School of Medicine, Stanford University, Stanford, California; and

California Perinatal Quality Care Collaborative, Stanford, California.

出版信息

Pediatrics. 2020 Jul;146(1). doi: 10.1542/peds.2019-3865. Epub 2020 Jun 18.

Abstract

OBJECTIVES

To examine trends in survival without major morbidity and its individual components among very low birth weight infants across California and assess remaining gaps that may be opportune targets for improvement efforts.

METHODS

The study population included infants born between 2008 and 2017 with birth weights of 401 to 1500 g or a gestational age of 22 to 29 weeks. Risk-adjusted trends of survival without major morbidity and its individual components were analyzed. Survival without major morbidity was defined as the absence of death during birth hospitalization, chronic lung disease, severe peri-intraventricular hemorrhage, nosocomial infection, necrotizing enterocolitis, severe retinopathy of prematurity or related surgery, and cystic periventricular leukomalacia. Variations in adjusted rates and/or interquartile ranges were examined. To assess opportunities for additional improvement, all hospitals were reassigned to perform as if in the top quartile, and recalculation of predicted numbers were used to estimate potential benefit.

RESULTS

In this cohort of 49 333 infants across 142 hospitals, survival without major morbidity consistently increased from 62.2% to 66.9% from 2008 to 2017. Network variation decreased, with interquartile ranges decreasing from 21.1% to 19.2%. The largest improvements were seen for necrotizing enterocolitis and nosocomial infection. Bronchopulmonary dysplasia rates did not change significantly. Over the final 3 years, if all hospitals performed as well as the top quartile, an additional 621 infants per year would have survived without major morbidity, accounting for an additional 6.6% annual improvement.

CONCLUSIONS

Although trends are promising, bronchopulmonary dysplasia remains a common and persistent major morbidity, remaining a target for continued quality-improvement efforts.

摘要

目的

研究加利福尼亚州极低出生体重儿(VLBW)无重大发病率和其各组成部分的生存率趋势,并评估可能有改进空间的剩余差距,作为努力的目标。

方法

研究人群包括出生体重为 401 至 1500 克或胎龄为 22 至 29 周的 2008 年至 2017 年出生的婴儿。分析无重大发病率和其各组成部分的生存率风险调整趋势。无重大发病率生存率定义为出生住院期间无死亡、慢性肺病、严重脑室周围出血、医院感染、坏死性小肠结肠炎、严重早产儿视网膜病变或相关手术、和囊性脑室周围白质软化症。检查调整后率和/或四分位间距的差异。为评估进一步改进的机会,所有医院均重新分配以达到最高四分位数水平,并重新计算预测数量以估计潜在益处。

结果

在这个由 142 家医院的 49333 名婴儿组成的队列中,无重大发病率的生存率从 2008 年到 2017 年从 62.2%持续增加到 66.9%。网络差异缩小,四分位间距从 21.1%缩小到 19.2%。最大的改善见于坏死性小肠结肠炎和医院感染。支气管肺发育不良率没有显著变化。在最后 3 年,如果所有医院的表现都像最高四分位数水平一样好,每年将有 621 名婴儿能够在无重大发病率的情况下存活,这意味着每年额外提高 6.6%。

结论

尽管趋势令人鼓舞,但支气管肺发育不良仍然是一种常见且持续的重大发病率,仍然是持续质量改进努力的目标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验